Loading...

QNTM

QNTM

QUANTUM BIOPHARMA LTD

(QNTM)

2025 6-K

Corporate Update

2 Jun '26

Company Filing Report

2 Jun '26

Filing Report

18 May '26

Filing Announcement

7 May '26

Financial Filing Report

6 May '26

Filing Report

22 Apr '26

Filing Update

2 Apr '26

Filing Update

1 Apr '26

Filing Report

30 Mar '26

Filing Report

27 Mar '26

Filing Overview

26 Mar '26

Filing Notification

23 Mar '26

Filing Reported

23 Dec '25

ATM Offering Agreement

22 Dec '25

Company Filing Update

22 Dec '25

Filing Information

19 Dec '25

Offering Termination

11 Dec '25

Offering Termination

8 Dec '25

Filing Reported

1 Dec '25

Filing Reported

28 Nov '25

Filing Report

26 Nov '25

Company Filing Update

25 Nov '25

Filing Update

7 Nov '25

Financial Results Report

6 Nov '25

ATM Offering Announcement

31 Oct '25

Filing Summary

28 Oct '25

Filing Update

28 Oct '25

Filing Update

28 Oct '25

Filing Correction

28 Oct '25

Filing Amendment

28 Oct '25

Filing Update

23 Oct '25

Filing Notification

14 Oct '25

Filing Update

8 Oct '25

Filing Update

3 Oct '25

Foreign Issuer Report

2 Oct '25

Filing Notification

1 Oct '25

Filing Update

29 Sep '25

Filing Update

24 Sep '25

Filing Details

18 Sep '25

Filing Summary

12 Sep '25

Filing Report

10 Sep '25

Quantum Filing Report

21 Aug '25

Foreign Issuer Report

11 Aug '25

Filing Notification

8 Aug '25

Filing Notification

7 Aug '25

Financial Report Filed

6 Aug '25

Form 6-K Filing

5 Aug '25

Filing Confirmation

4 Aug '25

Filing Notice

31 Jul '25

Filing Notification

22 Jul '25

Filing Summary

8 Jul '25

Filing Notification

27 Jun '25

Filing Overview

26 Jun '25

6-K Filing

17 Jun '25

Financial Filing Update

16 Jun '25

Form 6-K Filing

13 Jun '25

Filing Announcement

10 Jun '25

Filing Information

3 Jun '25

Filing Confirmation

30 May '25

Quantum Filing Update

29 May '25

Filing Report Summary

28 May '25

6-K Filing Summary

21 May '25

Filing Update

20 May '25

Quantum Filing Report

19 May '25

Filing Report

16 May '25

Financial Update

14 May '25

Company Filing Update

12 May '25

Company Filing Update

5 May '25

Filing Reported

24 Apr '25

Filing Update

22 Apr '25

Form 6-K Filing

18 Apr '25

SEC Form 6-K

14 Apr '25

Filing Announcement

10 Apr '25

Filing Notification

3 Apr '25

Form 6-K Filing

1 Apr '25

Filing Update

31 Mar '25

SEC Filing Notice

28 Mar '25

Filing Report

27 Mar '25

6-K Filing Summary

26 Mar '25

Filing Notification

20 Mar '25

Filing Date Notice

26 Feb '25

Filing Report

18 Feb '25

6-K Filing Summary

11 Feb '25

Filing Confirmation

10 Feb '25

Filing Confirmation

6 Feb '25

6-K Filing Report

4 Feb '25

Funding Update

21 Jan '25

Filing Report

17 Jan '25

Filing Notice

14 Jan '25

Filing Notification

7 Jan '25

Filing Report

20 Dec '24

Filing Notification

25 Nov '24

Quantum Biopharma Update

12 Nov '24

Filing Notification

29 Oct '24

Quantum Filing Update

22 Oct '24

Lawsuit Announcement

21 Oct '24

Distribution Agreement

7 Oct '24

Corporate Update

27 Sep '24

Private Placement Closure

16 Sep '24

Clinical Study Agreement

9 Sep '24

Compliance Regained

6 Sep '24

Celly Nutrition Launch

30 Aug '24

License Agreement Update

26 Aug '24

Debt Settlement Update

26 Aug '24

Financial Filing Update

19 Aug '24

Name Change & Split

15 Aug '24

Name Change Announcement

15 Aug '24

Filing Amendment

14 Aug '24

Filing Report Summary

14 Aug '24

Corporate Changes

12 Aug '24

Filing Report

9 Aug '24

FSD Pharma Report

29 Jul '24

Shareholder Meeting Notice

8 Jul '24

Regulatory Filing

8 Jul '24

Filing Report

28 Jun '24

FSD Filing Summary

28 Jun '24

FSD Filing Update

27 Jun '24

6-K Filing Summary

13 Jun '24

Monthly Filing Report

4 Jun '24

FSD Filing Update

31 May '24

Form 6-K Filing

28 May '24

Filing Notification

24 May '24

FSD Filing Report

16 May '24

FSD Pharma Filing

15 May '24

FSD Pharma Update

7 May '24

FSD Pharma Filing

30 Apr '24

FSD Pharma Filing

25 Apr '24

FSD Pharma Filing

22 Apr '24

FSD Pharma Filing

17 Apr '24

Company Filing Update

15 Apr '24

Filing Confirmation

15 Apr '24

Nasdaq Deficiency Notice

9 Apr '24

Company Filing Update

27 Mar '24

FSD Pharma Filing

11 Mar '24

6-K Filing Update

5 Mar '24

Regulatory Filing

28 Feb '24

FSD Filing Update

26 Feb '24

Litigation Update

21 Feb '24

6-K Filing Overview

20 Feb '24

ATM Agreement Announcement

20 Feb '24

Litigation Update

7 Feb '24

Filing Report

7 Feb '24

Litigation Update

16 Jan '24

External Links:

SEC

Quantum BioPharma Ltd. decided to terminate its At The Market Offering Agreement with H.C. Wainwright & Co. on December 6, 2025, which will end on December 20, 2025; they had not sold any shares yet under this agreement despite a potential offering of $21,225,000.

AI Assistant

QUANTUM BIOPHARMA LTD

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.